X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gastroenterology & hepatology (36) 36
index medicus (36) 36
analysis (28) 28
hepatitis c (28) 28
humans (28) 28
middle aged (26) 26
female (25) 25
hepatitis c virus (25) 25
male (25) 25
ribavirin (25) 25
aged (24) 24
genetic aspects (21) 21
interferon (20) 20
hepatitis (18) 18
adult (17) 17
care and treatment (16) 16
chronic hepatitis c (16) 16
cirrhosis (16) 16
liver cirrhosis (16) 16
patients (16) 16
hepatitis c, chronic - drug therapy (14) 14
pegylated interferon (14) 14
treatment outcome (14) 14
genotype (13) 13
genotypes (12) 12
multivariate analysis (12) 12
telaprevir (12) 12
aged, 80 and over (11) 11
antiviral agents - therapeutic use (11) 11
biological response modifiers (11) 11
genotype & phenotype (11) 11
health aspects (11) 11
hemodialysis (11) 11
drug therapy, combination (10) 10
hepacivirus - genetics (10) 10
hepatology (10) 10
japanese patients (10) 10
medical research (10) 10
medicine, experimental (10) 10
plus ribavirin (10) 10
combination therapy (9) 9
gastroenterology (9) 9
vitamin d (9) 9
daclatasvir (8) 8
hcv (8) 8
hepatitis c, chronic - virology (8) 8
hepatocellular carcinoma (8) 8
interferon-alpha - therapeutic use (8) 8
prospective studies (8) 8
safety (8) 8
virus-infection (8) 8
young adult (8) 8
hepatocellular-carcinoma (7) 7
interleukins - genetics (7) 7
japan (7) 7
liver cancer (7) 7
medicine & public health (7) 7
ribavirin - therapeutic use (7) 7
sustained virological response (7) 7
therapy (7) 7
antiviral agents - adverse effects (6) 6
chronic infection (6) 6
chronic kidney disease (6) 6
daclatasvir plus asunaprevir (6) 6
fibrosis (6) 6
genotype 1 (6) 6
kidney diseases (6) 6
liver (6) 6
liver cirrhosis - complications (6) 6
open-label (6) 6
peginterferon alpha-2b (6) 6
polyethylene glycols - therapeutic use (6) 6
recombinant proteins - therapeutic use (6) 6
sofosbuvir (6) 6
surgical oncology (6) 6
adolescent (5) 5
albumin (5) 5
alfacalcidol (5) 5
antiviral agents - administration & dosage (5) 5
asunaprevir (5) 5
biomarkers - blood (5) 5
calcifediol (5) 5
chronic kidney failure (5) 5
colorectal surgery (5) 5
dialysis patients (5) 5
efficacy (5) 5
glomerular filtration rate (5) 5
hepatitis c, chronic - genetics (5) 5
internal medicine (5) 5
liver diseases (5) 5
management (5) 5
medical colleges (5) 5
oligopeptides - therapeutic use (5) 5
ombitasvir/paritaprevir/ritonavir (5) 5
oncology (5) 5
peginterferon (5) 5
portal hypertension (5) 5
rapid virological response (5) 5
refractory ascites (5) 5
rna, viral - blood (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nihon Ika Daigaku Igakkai Zasshi, ISSN 1349-8975, 06/2019, Volume 15, Issue 3, pp. 106 - 114
Journal Article
Journal Article
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 1/2017, Volume 52, Issue 1, pp. 94 - 103
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 02/2018, Volume 67, Issue 2, pp. 505 - 513
Glecaprevir (nonstructural protein 3/4A protease inhibitor) and pibrentasvir (nonstructural protein 5A inhibitor) (G/P), a coformulated once‐daily, all oral,... 
ASIA | SOFOSBUVIR | CIRRHOSIS | PHASE-3 TRIAL | PREVALENCE | RIBAVIRIN | GASTROENTEROLOGY & HEPATOLOGY | BURDEN | Cirrhosis | Antiretroviral drugs | Hepatitis | Chronic infection | Infections | Interferon | Safety | Hepatitis C | Patients | Ribavirin | Genotypes | Original
Journal Article
Gastroenterology, ISSN 0016-5085, 05/2019, Volume 156, Issue 6, pp. S-1348 - S-1348
Journal Article